Response to “Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data”

Detalles Bibliográficos
Autores principales: Garcia‐Cremades, Maria, Solans, Belen P., Hughes, Emma, Ernest, Jacqueline P., Wallender, Erika, Savic, Radojka M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267305/
https://www.ncbi.nlm.nih.gov/pubmed/32348544
http://dx.doi.org/10.1002/cpt.1873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267305/
https://www.ncbi.nlm.nih.gov/pubmed/32348544
http://dx.doi.org/10.1002/cpt.1873

Ejemplares similares